COVID-19 Impact on Clinical Trials

COVID-19 Impact on Clinical Trials

We have all become well acquainted with the overwhelming sense of unpredictability that has cast a shadow on our world from the growing spread of COVID-19. Challenges have arisen from quarantines, site closures, travel limitations, interruptions to supply chains, and...
Catalyst Response to COVID-19

Catalyst Response to COVID-19

To our valued customers and colleagues: In the wake of the COVID-10 crisis, we have listened to understand the impact that COVID-19 is having on the BioPharma, Medical Device and CRO industries, and beyond. We share our deepest sympathy for the individuals and...
A Spotlight on Noonan Syndrome

A Spotlight on Noonan Syndrome

In advance and support of Rare Disease Day taking place this Saturday, February 29, we will continuing featuring rare diseases throughout the week to bring awareness to these uncommon, yet impactful illnesses.  NOONAN SYNDROME (NS) is a multisystem disorder...
A Spotlight on Allan-Herndon-Dudley

A Spotlight on Allan-Herndon-Dudley

In advance and support of Rare Disease Day taking place this Saturday, February 29, we will continue featuring rare diseases throughout the week to bring awareness to these uncommon, yet impactful illnesses.  Those living with rare diseases often experience...
A Spotlight on Schwartz Jampel Syndrome

A Spotlight on Schwartz Jampel Syndrome

In advance and support of Rare Disease Day taking place this Saturday, February 29, we will continue featuring rare diseases throughout the week to bring awareness to these uncommon, yet impactful illnesses.  SCHWARTZ JAMPEL SYNDROME (SJS) is a rare genetic disorder...
A Spotlight on Rett Syndrome

A Spotlight on Rett Syndrome

Rare Disease Day is recognized on the last day of February each year. The main objective of the initiative is to raise awareness amongst the general public and decision-makers for the 300 million people affected by rare diseases globally and the impact these diseases...